Estonia tops EU drug overdose deaths list

Officials in Estonia raised the alarm Wednesday after a report into drug use in Europe found that the small Baltic nation had the highest incidence of deaths from drug overdoses in the EU.

Last year, 160 people died from overdoses, data from the Europe Monitoring Centre for Drugs and Addictions (EMCDDA) showed, an increase of 21 percent from last year.

Most of the deaths were caused by taking a highly addictive form of synthetic heroin known as China White, which is often smuggled in from Russia.

"More people per million inhabitants perish in Estonia than in any other EU country due to , and most of these deaths are related to drugs called 'China White'," Ave Talu, head of Estonia's Drug Monitoring Centre, told AFP.

While the average number of deaths from overdoses across the 27-member EU bloc stands at up to 20 people per million, in Estonia the figure is five times higher, at over 100 per million.

In 2011, 132 people died from in the former Soviet nation of 1.3 million people.

Most of the people who died in 2012 were ethnic Russian men, the EMCDDA data showed.

Using a new to synthetic heroin, , could "cut the death rates from overdose nearly in half," Talu said.

But the drug is not yet available on a community outreach basis, she said.

"In Estonia, naloxone is used only by medical staff and unlike some other countries like the US, we do not yet have community-based naloxone distribution and training programmes, but they are urgently needed."

add to favorites email to friend print save as pdf

Related Stories

Australia: Heroin and opioid deaths on the rise

Oct 10, 2012

A total of 500 Australians aged 15 to 54 died from accidental opioid overdoses in 2008 and preliminary estimates suggest deaths of this nature will be higher again in 2009 and 2010, according to the National ...

Alcohol causes a quarter of Europe road deaths

Dec 15, 2012

Alcohol abuse is responsible for around a quarter of the 30,000 people who die in road accidents across the European Union every year, the bloc's drugs agency said in a report published on Friday.

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments